(Q43239617)

17 November 2017

title

Interactions with GluR1 AMPA receptors could influence the therapeutic usefulness of minocycline in ALS. (English)

1 reference

amyotrophic lateral sclerosis

17 November 2017

main subject

1 reference

1 reference

Hari Manev

1

1 reference

17 November 2017

Radmila Manev

series ordinal

2

1 reference

17 November 2017

publication date

1 October 2009

1 reference

Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders

17 November 2017

published in

1 reference

17 November 2017

volume

10

1 reference

17 November 2017

issue

5-6

1 reference

17 November 2017

page(s)

416-417

1 reference

A novel, efficient, randomized selection trial comparing combinations of drug therapy for ALS.

17 November 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F17482960802702288

Minocycline for patients with ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482960802702288

Neuroprotectant minocycline depresses glutamatergic neurotransmission and Ca(2+) signalling in hippocampal neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482960802702288

Altered presymptomatic AMPA and cannabinoid receptor trafficking in motor neurons of ALS model mice: implications for excitotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482960802702288

Desipramine or glutamate antagonists synergized the antidepressant-like actions of intra-nucleus accumbens infusions of minocycline in male Wistar rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482960802702288

Improvement by minocycline of methamphetamine-induced impairment of recognition memory in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482960802702288

10.3109/17482960802702288

21 January 2018

Identifiers

DOI

1 reference

17 November 2017

1 reference